Healthcare & Life Sciences
BerGenBio
Norwaywww.bergenbio.com/
BerGenBio is a Healthcare & Life Sciences startup based in Norway, since acquired, 2 tracked investors.
Acquiredacquired
acquired
Stage
2
Investors
About BerGenBio
BerGenBio is a company headquartered in Norway. BerGenBio has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
BerGenBio developed first-in-class AXL inhibitors targeting aggressive diseases, particularly in oncology, before merging with Oncoinvent ASA in 2025.
Explore BerGenBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.